Abstract:Non-small cell lung cancer (NSCLC) is radioresistant to X-rays due to powerful cellular DNA damage repair mechanisms. DNA-dependent protein kinase (DNA-PK) is a key enzyme involved in DNA damage repair and the phenomenon and molecular mechanism of NSCLC radionsensitivity were investigated following inhibition of DNA-PK activity. In the present study A549 cells were treated with the DNA-PK inhibitor NU7026 and/or siRNA directed against ataxia telangiectasia mutated (ATM), followed by exposure to 4 Gy X-ray irradiation. Radiosensitivity, DNA damage, apoptosis and protein expression were measured by colony formation assay, H2AX foci immunofluorescence, Annexin V/PI staining and western blotting, respectively. A Balb/c-nu/nu xenograft mouse model was established by subcutaneous injection of A549 cells and was used to examine the effect of administering NU7026 via intraperitoneal injection prior to 4 Gy X-ray exposure. The xenograft tumors were weighed and observed by hematoxylin and eosin staining after irradiation. NU7026 treatment followed by X-ray irradiation significantly decreased the colony formation ratio of A549 cells, and increased H2AX foci and cell apoptosis. Furthermore, the combined treatment of NU7026 and X-rays resulted in growth inhibition and cell apoptosis in A549 xenograft tumors. Consequently, apoptosis regulators full-length transactivating (TA) p73 and an N-terminally truncated (DN) p73 were upregulated and downregulated respectively, leading to activation of glucosyltransferases and Rab-like GTPase activators and myotubularins domain-containing 4 (GRAMD4) protein to reduce the Bcl-2/Bax protein ratio. In addition, ATM siRNA efficiently prevented H2AX foci formation, and enhanced NU7026-induced inhibition of survival and promoted apoptosis. In conclusion, inhibition of DNA-PK activity increased the radiosensitivity of A549 cells to X-ray irradiation. NU7026 treatment activated the ATM-dependent DNA damage response and induced p73 apoptosis pathway. DNA-PK inhibitor may be an effective constituent of radiosensitization products. DNA damage repair pathway could be a potential target for radiosensitization.

Selective ATM inhibition augments radiation-induced inflammatory signaling and cancer cell death

ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I

Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

ATM Expression is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency

Discovery of novel ataxia telangiectasia mutated (ATM) kinase modulators: Computational simulation, biological evaluation and cancer combinational chemotherapy study

Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection

Targeted Inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 Modulate Response to X Rays and Protons

Progress of ATM Inhibitors: Opportunities and Challenges

Ataxia-Telangiectasia Mutated (atm) Participates in the Regulation of Ionizing Radiation-Induced Cell Death Via Mapk14 in Lung Cancer H1299 Cells

ATR inhibition radiosensitizes cells through augmented DNA Damage and G2 cell cycle arrest abrogation

Perspectives on the Combination of Radiotherapy and Targeted Therapy with DNA Repair Inhibitors in the Treatment of Pancreatic Cancer.

Potentiating the radiation-induced type I interferon antitumoral immune response by ATM inhibition in pancreatic cancer

Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer

The Role and Mechanism of ATM-Mediated Autophagy in the Transition from Hyper-Radiosensitivity to Induced Radioresistance in Lung Cancer under Low-Dose Radiation.

ATM Inhibition Enhances the Efficacy of Radiation Across Distinct Molecular Subgroups of Pediatric High-Grade Glioma.

Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Inhibition of DNA‑PK Activity Sensitizes A549 Cells to X‑ray Irradiation by Inducing the ATM‑dependent DNA Damage Response

Antisense Inhibition of ATM Gene Enhances the Radiosensitivity of Head and Neck Squamous Cell Carcinoma in Mice

Inhibition Of Atr Downregulates Pd-L1 And Sensitizes Tumor Cells To T Cell-Mediated Killing

Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR)